Updated:
Upcoming Grifols dividendGrifols has not established any dividends for 2026.
Grifols paid a dividend of 0.08237931 euros on July 2, 2026, corresponding to a yield of 0.92%.
Grifols has opted for a low dividend policy over the years. Always with a dividend yield of less than 2%.
In recent years they have divided the fiscal years into two payment dates, one at the end of the year of the fiscal year in question, and the other in the middle of the following year.
They are currently having problems distributing part of the profits to shareholders due to the company's large debt.
Join +33,000 investors who get notifications, analysis and news.
Dividend calendar of Grifols
There is no Dividend Calendar of Grifols defined for 2026.
Dividend history of Grifols
In this table you can see the complete history:
| Year | Ex-Dividend | Amount | Total |
|---|---|---|---|
| 2026 |
06/30/2026 |
0.08237931 € |
0.0824 € |
| 2025 |
08/11/2025 |
0.15 € |
0.15 € |
| 2021 |
06/03/2021 |
0.364348 € |
0.3643 € |
| 2020 |
10/26/2020 |
0.1616 € |
0.1616 € |
| 2019 |
12/02/2019 06/07/2019 |
0.2 € 0.145142 € |
0.3451 € |
| 2018 |
11/30/2018 06/01/2018 |
0.2 € 0.203996 € |
0.404 € |
| 2017 |
12/01/2017 05/30/2017 |
0.18 € 0.135615 € |
0.3156 € |
| 2016 |
12/05/2016 06/02/2016 |
0.18 € 0.132572 € |
0.3126 € |
| 2015 |
12/10/2015 06/08/2015 |
0.175 € 0.147545 € |
0.3225 € |
| 2014 |
12/04/2014 06/05/2014 |
0.125722 € 0.100342 € |
0.2261 € |
| 2013 |
06/05/2013 |
0.1 € |
0.1 € |
| 2010 |
07/01/2010 |
0.063946 € |
0.0639 € |
| 2009 |
12/18/2009 06/02/2009 |
0.076528 € 0.116048 € |
0.1926 € |
| 2008 |
06/23/2008 |
0.071935 € |
0.0719 € |
| 2007 |
07/02/2007 |
0.030171 € |
0.0302 € |
Information about Grifols
Grifols is a Spanish biotechnology and pharmaceutical company. It was founded in 1940 and is headquartered in Barcelona, Spain. It is listed on the Spanish stock exchange and is part of the IBEX 35 index.
It is principally engaged in the research, development, production and marketing of therapeutic products derived from blood plasma. These products include coagulation factors, albumin, antibodies and alpha-1 protease inhibitor.
The company has won several awards for its commitment to quality and safety. It is currently active in Europe, North America, Latin America, Asia and Africa and is one of the world's leading manufacturers of plasma-based products. In addition, it has a network of more than 30,000 plasma donors worldwide.
Frequently asked questions about Grifols dividends
Grifols is listed on the Madrid Stock Exchange and is part of the Ibex 35.
Grifols has the Ticker or stock code BME:GRF.
The CEO of Grifols in 2026 is Mr. Víctor Grifols Deu.
The ISIN of Grifols is ES0171996087.
Check the latest comments and participate in the live chat on Grifols stocks (GRF).
No comments yet. Be the first to join in.
